Losartan can cause itching and a range of skin reactions, though most are uncommon. Skin-related complaints reported with this widely prescribed blood pressure medication span from mild rashes and sun sensitivity to rare but serious conditions like angioedema and drug-induced vasculitis. The likelihood of any individual developing a skin problem on losartan is low, but the drug does carry a somewhat higher rate of skin-related adverse event reports compared to other medications in its class, which makes it worth understanding what to watch for.
Everyday Skin Complaints on Losartan
The most frequently reported skin-related side effects of losartan are mild and nonspecific: occasional itching, hives, and generalized rash. These are listed in the drug’s prescribing information and show up across post-marketing surveillance databases. For most people who experience them, the symptoms are annoying rather than dangerous. They can appear within days to weeks of starting the medication, or sometimes only after months of use. The itching tends to be diffuse rather than localized to one spot, and it may or may not come with a visible rash.
What makes these reactions tricky to pin down is that many people taking losartan are older adults on multiple medications. Itching and rashes are common complaints in that population for reasons that have nothing to do with any particular drug. Dry skin, contact allergies, and other medications in the mix can all cloud the picture. If you develop mild itching shortly after starting or increasing a dose of losartan, the timing is a useful clue, but it is not proof. Your prescriber will typically consider the timeline, rule out other obvious causes, and sometimes try a brief discontinuation to see if the itching resolves.
Photosensitivity and Sun Reactions
One skin reaction that tends to fly under the radar is photosensitivity, where your skin becomes unusually sensitive to sunlight while you are on the medication. A large retrospective study that examined the World Health Organization’s global adverse-event database found over 200 reports of photosensitivity linked to angiotensin receptor blockers (the drug class losartan belongs to). About a quarter of those reports involved losartan specifically, making it one of the most commonly implicated drugs in the class alongside irbesartan. The analysis found a possible positive statistical signal connecting photosensitivity to both losartan and irbesartan. Among well-documented cases where no other photosensitizing drug was being taken, losartan accounted for a third of the reports.
1PubMed. Photosensitivity with Angiotensin II Receptor Blockers: A Retrospective Study Using Data from VigiBasePhotosensitivity from losartan can look like an exaggerated sunburn, with redness, blistering, or an itchy rash appearing on sun-exposed skin after what would normally be a harmless amount of time outdoors. If you have recently started losartan and notice that your skin seems to burn or react faster than usual in the sun, photosensitivity is a reasonable suspicion. Wearing sunscreen and protective clothing is the practical first step, but if the reactions are severe or recurrent, your doctor may consider switching to a different medication in the same class that carries a weaker photosensitivity signal.
Angioedema
Angioedema is a deeper form of swelling that affects the tissue under the skin, often around the face, lips, tongue, or throat. It is the most medically urgent skin-related reaction linked to losartan. Unlike a surface rash, angioedema can compromise breathing if the swelling involves the airway. Published case reports describe episodes ranging from moderate facial and lip swelling to situations severe enough to require emergency airway management. One report documented a case of losartan-induced angioedema in a 48-year-old man that progressed to the point of needing a tracheostomy to maintain his airway.2PubMed Central. Losartan-Induced Angioedema: A Case Report Another described a patient who experienced two distinct episodes of angioedema within a single 10-hour period, both of which resolved with treatment.3PubMed. Losartan-induced angioedema
Angioedema from losartan is rare in absolute terms, but it is well-documented enough to be a recognized risk. The mechanism is thought to involve the way losartan and similar drugs interact with pathways that regulate bradykinin, a substance that causes blood vessels to dilate and become leaky. This is the same general mechanism behind the more commonly recognized angioedema caused by ACE inhibitors like lisinopril and enalapril. If you experience sudden swelling of your lips, tongue, or throat while taking losartan, treat it as a medical emergency and get to an emergency department immediately, even if the swelling seems mild at first.
Rare but Serious Skin Reactions
Beyond the common rashes and the urgent threat of angioedema, losartan has been linked in case reports to several rare but severe skin conditions. These are individually very uncommon, but they are worth knowing about because early recognition can make the difference between a manageable illness and a life-threatening one.
DRESS Syndrome
DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) is a delayed hypersensitivity reaction that typically shows up two to eight weeks after starting a medication. It involves widespread rash, fever, swollen lymph nodes, and internal organ involvement, usually the liver or kidneys. One published case involved a 62-year-old man who presented with a 10-day history of widespread itchy, scaly red lesions covering his face, chest, abdomen, and limbs, along with crusted lesions on his jaw, ears, and back. In DRESS syndrome generally, maculopapular rashes (flat or slightly raised red patches) occur in the vast majority of cases, while blistering or mucosal involvement is less common.4Acta Medica Colombiana. Losartan-induced DRESS syndrome DRESS is treated by stopping the offending drug immediately and often requires corticosteroids.
Stevens-Johnson Syndrome
Stevens-Johnson syndrome (SJS) is a rare, potentially fatal condition in which the skin and mucous membranes blister and peel. It is estimated to occur at a rate of roughly 1 to 6 cases per million people per year across all drug causes. Losartan-induced SJS has been reported, though it remains very rare. Because SJS carries significant mortality risk, clinicians are advised to maintain vigilance when prescribing antihypertensive medications, particularly in older patients who may be on multiple drugs simultaneously.5International Journal of Pharmaceutical Sciences. Losartan-H Induced Steven Johnson’s Syndrome – A Case Report The hallmark early signs are painful skin, unexplained widespread rash, and blistering or erosion of mucous membranes such as the mouth, eyes, or genitals. Any combination of these symptoms warrants immediate medical attention.
Vasculitis
Drug-induced vasculitis, an inflammation of small blood vessels in the skin, has also been reported with losartan. One case described a patient who developed severe pustular vasculitis while taking losartan as their only medication. Skin biopsies showed leukocytoclastic vasculitis with blistering and antibody deposits. The lesions cleared after stopping losartan and treating with a tapering course of corticosteroids.6PubMed. Severe pustular and polymorphous vasculitis caused by losartan Vasculitis typically appears as purplish spots or raised bumps, often on the lower legs, sometimes accompanied by joint pain or systemic symptoms. It is rare with losartan but has been reported enough times to be a recognized association.
How Losartan Compares to Other ARBs for Skin Problems
If you are on losartan and experiencing skin reactions, one natural question is whether switching to a different ARB would help. The evidence suggests it might. A recent analysis of the U.S. Food and Drug Administration’s adverse event reporting system compared skin disorder reports across several ARBs, using losartan as the reference. The reporting proportion for skin disorders was higher for losartan than for every other ARB examined. For context, losartan’s reporting proportion was about 10.6, compared to 6.1 for valsartan and 4.2 for olmesartan. The differences were statistically significant even after adjusting for other variables.7PubMed Central. Comparison of Adverse Events Among Angiotensin Receptor Blockers in Hypertension Using the United States Food and Drug Administration Adverse Event Reporting System
These numbers come from spontaneous reports rather than controlled trials, so they need some caution. Losartan is one of the most widely prescribed ARBs and has been on the market longer than some of its competitors, which can inflate its reporting numbers simply because more people take it and more clinicians are familiar with reporting reactions to it. Still, the consistency of the pattern across multiple other ARBs is hard to dismiss entirely. If skin problems are a recurring issue for you on losartan and your blood pressure needs to stay managed by an ARB, asking your doctor about trying a different one is reasonable. Olmesartan and telmisartan showed particularly low skin disorder reporting proportions in the same analysis.
Switching from an ACE Inhibitor to Losartan
A large number of people end up on losartan specifically because they had problems on an ACE inhibitor, most often the notorious dry cough or, more seriously, angioedema. A common clinical question is whether switching to an ARB like losartan is safe if you had angioedema on an ACE inhibitor. The concern is cross-reactivity: both drug classes act on overlapping biological pathways, so a reaction to one might recur with the other.
The reassuring news is that the cross-reactivity rate appears to be low. A large nationwide registry-based study followed patients who had experienced angioedema on ACE inhibitors and then switched to ARBs. Rather than finding a heightened risk, the study found that patients on ARBs actually had a lower rate of angioedema compared to patients on other classes of antihypertensives, with an adjusted hazard ratio of 0.39.8PubMed. Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors – a nationwide registry-based cohort study That finding is striking, suggesting that the switch is not only tolerable but may carry even lower absolute risk than some alternatives. Literature reviews of published case reports have estimated the cross-reactivity rate at less than 10%, and given the meaningful cardiovascular benefits of staying on an angiotensin-blocking drug, most guidelines support considering ARBs in patients who had angioedema on ACE inhibitors.9US Pharmacist. Cross-Reactivity of ACE Inhibitor–Induced Angioedema with ARBs
That said, if your ACE inhibitor angioedema was severe, involving airway compromise or an ICU stay, your doctor will weigh the decision more carefully. In those cases, some clinicians prefer to avoid the entire drug family and switch to a completely different class of blood pressure medication, like a calcium channel blocker. Others will start the ARB under monitored conditions to watch for a reaction. There is no single right answer; it depends on the severity of your prior episode and how much you stand to benefit from an angiotensin-blocking drug.
How Skin Reactions to Losartan Get Diagnosed
Figuring out whether losartan is really the cause of a skin reaction can be harder than it sounds, especially when you are taking several medications. The gold standard for proving a drug caused a reaction is re-challenge: stop the drug, see if the symptoms clear, then restart it and see if they return. In practice, deliberate re-challenge is risky and rarely done for anything beyond mild reactions. Nobody wants to re-trigger angioedema or DRESS syndrome just to prove a point.
Patch testing is one alternative. This involves applying the suspected drug directly to the skin under a controlled setting and watching for a localized reaction. For drug-related skin reactions, testing is generally recommended about three months after the eruption has fully resolved, using standardized techniques. Because commercially prepared test formulations exist for only a limited number of drugs, testing for losartan usually involves preparing the drug at various concentrations and in different vehicles.10PubMed Central. The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications Patch testing works best for delayed-type reactions like DRESS or fixed drug eruptions; it is less useful for immediate reactions like angioedema or urticaria, which involve different immune pathways.
In most real-world situations, the diagnosis ends up being clinical: your doctor looks at the timeline (when did the rash start relative to starting or changing the dose of losartan?), the pattern of the rash, the presence or absence of systemic symptoms like fever or organ involvement, and whether other causes are plausible. If stopping losartan clears the problem and nothing else changed, that is usually sufficient evidence to attribute the reaction to the drug and avoid it going forward.
Recognizing What Needs Urgent Attention
Most skin reactions to losartan are mild and manageable, but knowing the warning signs that separate a nuisance rash from a medical emergency is important. The reactions that require immediate care share a few features. Swelling of the lips, tongue, or throat suggests angioedema and can escalate to airway obstruction quickly. Widespread blistering, especially if it involves the mouth, eyes, or genital area, raises concern for Stevens-Johnson syndrome. A rash accompanied by high fever, swollen lymph nodes, or abnormal blood work points toward DRESS syndrome. Purplish spots on the lower legs that do not blanch when pressed could indicate vasculitis.
Mild itching or a faint rash without any of those features does not demand an emergency visit, but it does warrant a call to your prescriber. Even a minor reaction is useful information: it goes into your medical record, helps your doctor make decisions about whether to continue the drug, and can guide future prescribing. If the itching is bothersome while you wait for a follow-up appointment, over-the-counter antihistamines often provide relief for mild drug-related itching. Avoid applying topical steroids to large areas of your body without medical advice, since they can mask the progression of a more serious eruption.
One practical point worth emphasizing: if you stop taking losartan because of a skin reaction, do not simply stop it cold and wait for a doctor’s appointment days later. Abruptly stopping a blood pressure medication can cause a rebound spike in blood pressure. Call your prescriber or pharmacist for guidance on how to manage the gap, whether that means a temporary substitute or a supervised taper. The skin problem matters, but so does keeping your blood pressure under control while you sort it out.